Search clinical trials for: clofarabine (oral formulation)

Total 9473 results

University of Zurich
Ixodes GmbH; Appletree AG

Completed

Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation (IXO-01)

Lyme Disease

Switzerland
Pfizer

Completed

A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese

Obesity | Overweight

United States
Pendulum Therapeutics

Terminated

Placebo-Controlled Clinical Nutrition Study of the Metabolic Effects of Food Product WBF-0011 in Type 2 Diabetes

Type 2 Diabetes Mellitus

Ireland
University of Oxford
The Hospital for Sick Children; KEMRI-Wellcome Trust Collaborative Research... and other collaborators

Completed

Reformulated F75 Milk to Treat Severe Acute Malnutrition (F75)

Malnutrition | Metabolic Disturbance | Diarrhoea

Kenya, Malawi
Pfizer

Active, not recruiting

To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons. It Will Be Given Twice Over a Period of Time to Healthy Adults

Clostridoides Difficile Associated Disease

United States
University Hospital, Basel, Switzerland

Completed

Physiological Study of the Human CYP3A Activity (PiSA) (PiSA)

Cytochrome P450 CYP3A Enzyme Deficiency

Switzerland
GlaxoSmithKline

Completed

Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.

Infections, Papillomavirus

Belgium, United States
Lyndra Inc.

Terminated

Study Determining Gastric-Retentive and Modified Release Properties of Prototype Capsules in Healthy Subjects

Healthy | Gastric Retention

United Kingdom
Modra Pharmaceuticals

Completed

Extended Use of ModraDoc006/r

Advanced Solid Tumours

Netherlands
Karolinska Institutet

Not yet recruiting

Evaluation of the Cultural Formulation Interview (CFI)

Mental Health Issue

Sweden
MediWound Ltd

Completed

A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg Ulcers

Diabetic Foot Ulcer | Venous Leg Ulcer

United States
Bayer

Completed

In-home Use Test of the New Modified Diprobase Formulation to Assess the Safety and Tolerability in Infants and Children Under Physician's Control

Atopic Dermatitis

United Kingdom
Hamdard University

Completed

Comparative Anti Helicobacter Pylori Efficacy Assessment of Unani Formulation and Quintuple Regimen

H.Pylori Infection
University of Utah
Genzyme, a Sanofi Company

Terminated

Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Cancer | Chronic Myelomonocytic Leukemia

United States
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body With or Without Food

Healthy

Germany
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

The Cultural Formulation Interview-Engagement Aid (CFI-EA)

Communication | Adherence, Patient

United States
Mati Therapeutics Inc.

Completed

A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG

Ocular Hypertension | Glaucoma

United States
Modra Pharmaceuticals
The Netherlands Cancer Institute

Completed

Food Effect Study of ModraDoc006 in Combination With Ritonavir

Solid Tumor, Adult

Netherlands
Hellenic Cooperative Oncology Group
University of Ioannina

Completed

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

Breast Cancer | Prostate Cancer | Non Small Cell Lung Cancer

Greece
Modra Pharmaceuticals

Withdrawn

Absorption and Excretion of Oral Docetaxel

Solid Tumor, Adult

Netherlands
Modra Pharmaceuticals

Completed

ModraDoc006/r in Patients With Breast Cancer

Metastatic Breast Cancer | Recurrent Breast Cancer

Denmark, Belgium, Spain
Modra Pharmaceuticals
The Netherlands Cancer Institute

Completed

ModraDoc006/r in Metastatic Castration-resistant Prostate Cancer

Castration-resistant Prostate Cancer

Netherlands
Ian McGowan
National Institute of Allergy and Infectious Diseases (NIAID); CONRAD

Completed

A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally

HIV Prevention

United States
Cogent Biosciences, Inc.

Recruiting

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

Mastocytosis | Mastocytosis, Systemic | SSM | Mastocytosis, Indolent

United States, Italy, Canada, Australia, Spain, Switzerland, Norway, United Kingdom, Belgium, Poland, Netherlands, Germany, France, Czechia, Greece, Ireland
GlaxoSmithKline

Completed

Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions

Infections, Bacterial

South Africa
Sanofi

Completed

Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects

Influenza | Myxovirus Infection | Orthomyxoviruses

United States
Genzyme, a Sanofi Company

Completed

A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)

Lymphoblastic Leukemia, Acute, Childhood

United States
GlaxoSmithKline

Completed

Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women

Respiratory Syncytial Virus Infections

United States, Australia, Germany, Czechia
Finnish Institute of Occupational Health
The Social Insurance Institution of Finland; the Hospital District of Helsinki...

Active, not recruiting

Web-based Rehabilitation for Persistent Physical Symptoms. (DigiPimo)

Chronic Fatigue Syndrome | Persistent Physical Symptoms | Indoor Environment Associated Symptoms | Indoor Air Associated Symptoms

Finland
Braintree Laboratories

Completed

BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States
CSPC Ouyi Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Olaparib Tablets Under Fasting and Fed Conditions in Healthy Subjects

Healthy Participants

China
Tibotec Pharmaceuticals, Ireland

Completed

TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions

HIV Infections
Avon Products, Inc.
University of Cape Town, Groote Schuur Hospital

Not yet recruiting

16-Week Randomized Split-Face Efficacy Study of Cosmetic Formulations in Photoaged Pigmented Skin Subjects

Aging Problems | Pigmentation
Washington University School of Medicine

Terminated

A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Emory University
Micron Biomedical, Inc

Completed

Microneedle Patch Study in Healthy Infants/Young Children

Vaccination | Skin Absorption

United States
Takeda

Completed

A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers

Healthy

United States
Columbia University
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Obesity, Oral Contraception, and Ovarian Suppression (20/30)

Ovarian Suppression

United States
Merck Sharp & Dohme LLC

Completed

Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)

Cervical Cancer | Vulvar Cancer | Vaginal Cancer | Human Papillomavirus Infection | Genital Warts
Boehringer Ingelheim

Completed

Bioavailability of Different Pramipexole Slow-release Formulations Compared to Immediate-release Tablet in Healthy Male Volunteers

Healthy
Modra Pharmaceuticals

Withdrawn

Oral Docetaxel in Patients With Normal or Impaired Liver Function

Solid Tumor, Adult | Impaired Liver Function

Netherlands
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders

Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative Diseases

United States
Société des Produits Nestlé (SPN)

Completed

Lipid Formulation to Increase the Bioavailability of Fatty Acids in Cystic Fibrosis (CF) Patients

Cystic Fibrosis

Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults

Influenza

United States
Dana-Farber Cancer Institute

Withdrawn

Clofarabine for Langerhans in Pedi

Langerhans Cell Histiocytosis
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML1107)

Leukemia

Italy
Istituto Giannina Gaslini

Completed

Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In Children (CLOVE)

Acute Leukemia

Italy
Chong Kun Dang Pharmaceutical

Unknown

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers

Type2 Diabetes Mellitus
GlaxoSmithKline

Active, not recruiting

Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults

Influenza, Human

United States
GlaxoSmithKline

Completed

A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women

Respiratory Syncytial Virus Infections

United States, Belgium, Canada
Embera NeuroTherapeutics, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations

Cocaine Use Disorder

United States

3

Subscribe